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Abstract. In recent years, a great progress was achieved in the development of 
electrochemical sensors for DNA sequences, hybridization and damage. Nowadays, 
electrochemical methods are able to detect DNA at nanomolar concentration. In addition, 
these methods are suitable for studding both covalent and non-covalent binding 
interactions between DNA and different small molecules, e.g. drugs or potentially 
mutagenic agents. This suggests that electrochemical biosensors might become important 
tools in medical research. The aim of this review is to draw attention to the applicability 
of different electrochemical techniques for studying interactions between DNA with other 
molecules, and in the design of new sensitive and selective biosensors. 
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1. INTRODUCTION  
Deoxyribonucleic acid, DNA, [1-3], is a natural product of an enormous importance 
for the functioning of genetic processes such as growth, differentiation and aging of the 
cell. Binding of small organic and inorganic molecules to DNA can influence numerous 
biological processes in which DNA participate, like transcription and replication [2, 3]. 
These processes begin when DNA receives the signal from regulatory protein which binds 
to its particular part. If, instead of the regulatory protein, some other small molecule binds 
to DNA, its function is artificially changed–inhibited or activated. Such interference can 
retard or even prevent the cell growth, or, on the other hand, it can lead to excessive pro-
duction of some protein and uncontrolled cell growth. In the case when the activation or 
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inhibition of the DNA functions act in the way to cure or control the disease, small mole-
cule is denoted as a drug, otherwise it is cytotoxic agents. 
When the complex between small molecules and DNA is formed, both molecules, as 
well as DNA, experienced some modifications. Detection and explanation of these changes 
makes a great challenge for new instrumental methods. The development of the electro-
chemical DNA biosensors has opened a wide perspective using particularly sensitive and 
selective electrochemical methods for the detection of specific DNA interactions. The ob-
tained results are used to understand the correlation between DNA structure, sequence and 
activity, to confirm the DNA damage, to determine drug binding sites and sequence prefer-
ence, as well as conformational changes due to DNA-drug interaction. 
The aim of this review is to give the overview of the present state of DNA electro-
chemical analysis. The presented results summarize literature data obtained by the appli-
cation of electrochemical biosensors, their operation and detection principles, with em-
phasis on the use of the covalently or non-covalently bound redox indicators for increas-
ing the sensitivity of the measurements. The brief summary of the DNA structural char-
acteristic and types of interactions will be discussed before presenting the basic biosensor 
working principles. 
 
Fig. 1 Structure of double stranded DNA. Squares denote electroactive groups that can be 
reduced at mercury electrodes, and circles show sites oxidized at carbon electrodes. 
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2. STRUCTURAL CHARACTERISTICS AND ELECTROCHEMICAL ACTIVITY OF DNA MOLECULE 
Deoxyribonucleic acid, DNA, [1-3] consists of two long polynucleotide chains com-
posed of four types of nucleotide subunits. The nucleotides themselves are composed of 
five-carbon sugars (deoxyribose) to which one or more phosphate groups and a nitrogen-
containing base are attached. Base may be either adenine (A), cytosine (C), guanine (G), 
or thymine (T). The nucleotides are covalently linked together in a chain through the sug-
ars and phosphates, which thus form a “backbone” of alternating sugar and phosphate. 
The DNA secondary structure is represented by the double helix which consists of two 
antiparallel polynucleotide chains that are held together by hydrogen bonding between the 
bases of the different strands, where all the bases are situated inside of the sugar-phos-
phate backbones of the double helix (Figure 1). 
Electrochemical activity of DNA is a consequence of the redox properties of nucleo-
bases. Guanine and adenine residues are oxidized at carbon electrodes, while cytosine and 
adenine residues are reduced at mercury electrodes, in aqueous solutions at neutral pH. 
Thymine (T) is reduced only in non aqueous media at highly negative potentials [4-9]. Elec-
troactive groups that undergoes oxidation or reduction processes are presented at Figure 1. 
2.1. DNA interactions in aqueous environment 
In aqueous solution DNA is polyanion attracting positively charged counter ions (Na
+
, 
Ca
2+
 or Mg
2+
). Drug molecules are also often charged and thus associated with counter 
ions. The associated counter ions lie near the charged groups and are also partially solv-
ated. When the binding occurs, it results in a displacement of solvent from the binding 
site on both the DNA and drug. Also, since there would be partial compensation of 
charges as the DNA and the drug are oppositely charged, some counter ions would be 
released into the bulk solvent fully solvated. Besides the counter ion effect, there are other 
interactions that must be considered, e.g. hydration/dehydration process which occurs 
through drug–solvent (hydration shell) and DNA–solvent interaction. Hydration plays 
very important role in the stability of DNA molecule, as well as DNA complex, since this 
process is believed to be governing by the base sequence, also. 
Parts of a DNA molecule that can interact with small molecules are: negatively 
charged phosphate backbone (electrostatic interactions), the hydrogen accepting and do-
nating sites in the minor and major grooves (H-bonds), the phosphate oxygen atoms and 
aromatic hydrophobic components (van der Waals interactions). 
3. ELECTROCHEMICAL BIOSENSORS 
According to International Union of Pure and Applied Chemistry (IUPAC) an 
electrochemical biosensor is a self-contained integrated device, which is capable of 
providing specific quantitative or semi-quantitative analytical information using a biological 
recognition element (biochemical receptor) which is retained in direct spatial contact with an 
electrochemical transduction element [10]. The biological recognition system translates 
information from the biochemical domain, into a chemical or physical output signal with a 
defined sensitivity. The main purpose of the recognition system is to provide the sensor with 
a high degree of selectivity for the analyte to be measured. The transducer part of the sensor 
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serves to transfer the signal from the output domain of the recognition system, mostly to the 
electrical domain [11, 12]. Electrochemical biosensors intended to detect DNA presence or 
hybridization, DNA damage, or the binding of molecules to DNA. 
During the last decade of the 20
th
 century, DNA oligomers have been utilized as 
selective bio-recognition elements in new group of affinity biosensors. These so called 
DNA-based biosensors possess specificity of the response taking advantage of the 
bioaffinity properties of DNA. However, in contrast to conventional enzyme- and imuno-
sensors, the DNA biosensors are mostly used for the investigation of interactions of DNA 
itself rather than for typical determination of the concentration of an analyte [13-15]. An 
electrochemical DNA biosensor can be characterized as a device that integrates DNA as 
the biological recognition element and an electrode as the electrochemical transducer. It is 
often presented as an electrode chemically modified by nucleic acid. Advantages and 
successful use of the electrochemical DNA biosensors were reported and reviewed in 
numerous papers [16-22]. 
3.1. Operation principles 
The signal obtained at the modified electrode surface is transduced into the electrical 
signal. The measurement can be carried out both amperometrically and potentiometrically. 
In amperometric measurements, an external potential is applied to oxidize or to reduce an 
electrochemically active compound at its intrinsic redox potential, and the current 
produced during the process is measured. In potentiometric measurements, equilibrium is 
reached at the electrode surface without the need of the external potential, and as a 
consequence, the equilibrium potential between the electrode and the measured solution is 
generated and recorded [10, 11]. The possibility of setting the working potential to the 
specific redox value of the analyte of interest provides the greater selectivity for the 
amperometric detection. The procedure usually includes the following three steps: 
1) DNA immobilization on the electrode surface, 2) dipping the electrode into analyte 
solution, and 3) measuring of the current response. The first two steps are performed 
under the continuous stirring of the solution in order to ensure the adequate mass 
transport. If the measurement of the current response is performed from the same solution, 
it is always done after a quiescent period, or alternatively the measurements can be done 
applying the transfer technique: transferring the electrode with an adsorbed layer to a 
blank background electrolyte. The measured current intensity depends on the 
concentration of the analyte following the Cottrel’s equation: 
 
1/ 2
1/ 2 1/ 2
D
I nFA C
t
  (1) 
where A represents the area of the electrode, D is diffusion coefficient, C is concentration 
of the analyte, t is time during which the measurement is performed, and n is the number 
of exchanged electrons in the electrode process. The electrode used as transducer element 
can be made up from different materials such as platinum, gold, mercury, pyrolytic 
graphite, glassy carbon or carbon paste. The use of solid conductors dispersed into 
polymeric nonconducting matrices – composites, and nanostructured materials is growing 
over the last years. The large surface and characteristic conducting properties allow them 
to achieve better response times, higher sensitivity and improved specificity [23-25]. 
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Depending on the electrode material, DNA can be immobilized on the electrode 
surface using different techniques: physical adsorption, electrochemical adsorption, 
covalent binding, the use of avidid/biotin complex, or the electropolymerized monomers 
like pyrrole, with the role of trapping the DNA molecules and binding them to the 
electrode.  
3.2. Detection principles 
Regardless to the DNA immobilization technique, the fundamental principle of the 
detection is based on the fact that the electrode detects the change at the DNA molecule. 
The resulting modification may be due to the change in DNA concentration, orientation 
(conformation) or structure, caused by damage or denaturation. 
On the other hand, modification of the signal can also be caused by the non-covalent 
interactions of DNA with different ligands. One of the main principles of DNA chemistry 
is molecular recognition, the process when molecules (small or large) selectively 
recognize each other. This is manifested through a couple of interaction modes: 
electrostatic, hydrogen bonds, and van der Waals (dipole – dipole) interaction, which lead 
to hybridization, association or complex formation. The stability of the formed complex 
depends on the strength of the mentioned interactions. The most widely used substances 
that reversible bind to DNA are electroactive intercalators, and by measuring the change 
in redox signals derived from an electroactive intercalator, the interaction can be 
followed. 
The third type of interaction that can be registered by electrochemical biosensor, are 
the irreversible interactions among electroactive substances covalently bound to dsDNA 
(double-stranded, native DNA), used mostly for increasing the selectivity of analytical 
determination of DNA. 
Based on the above mentioned type of interactions, four different detection principles 
are utilized [16, 17]. 
3.2.1. Label-free technique 
Label-free technique is based on electrochemical and surface activity of DNA [26, 
27]. When nucleic acids interact with electrodes, they are usually strongly adsorbed. The 
adsorbed nucleic acid undergoes charge-transfer reactions, producing signals that can 
provide information about their concentration, changes in structure and orientation. 
Guanine and adenine undergo oxidation processes at glassy carbon electrodes. Oxidation 
of guanine occurs in two consecutive steps. The first step is irreversible two-electron/two-
proton oxidation to 8-oxoguanine, yielding peak at +0.8 V vs. Ag/AgCl [8], which is 
followed by one-electron reversible oxidation of the guanine dimers, at +0.95 V  [28]. 
The 8-oxoguanine formed at the electrode surface is further oxidized in reversible two-
electron/two-proton process [28]. Adenine oxidation is also irreversible, and occurs in 
three steps [9]. In cyclic voltammogram of adenine, three peaks are observable: the first 
one, at +1.05 V vs. Ag/AgCl, corresponds to adenine oxidation, the second at +1.12 V, to 
the oxidation of adenine dimmers, and the third one, which is detected after several scans, 
corresponds to oxidation of adenine electroactive products formed at the electrode surface 
[28]. DNA oxidation can be followed at other carbon electrodes, such as pyrolytic 
graphite, carbon paste, modified carbon electrodes, as well as with the tin-oxide electrode. 
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At neutral and weakly acidic pH, adenine, cytosine and guanine residues in DNA 
produce reduction signals at mercury-based electrodes close to -1.4 V vs. Ag/AgCl, and 
in cyclic modes guanine yields an anodic signal, at about -0.3 V vs. Ag/AgCl, due to the 
oxidation of its reduction product back to guanine [5]. The pH of the solution has an 
important role in the detection process, since protonation of bases is involved in the 
electrode process. Nucleic acids strongly adsorb on electrodes, especially on mercury and 
carbon. Ideally smooth and highly reproducible surface of liquid mercury is very well 
suited for ac (alternating current) impedance measurements, which can provide 
information about DNA adsorption/desorption properties. This adsorption/ desorption 
behavior of DNA depends on the structure of the DNA molecules, and its orientation on 
the electrode surface. Reduction signals of adenine and cytosine are strongly influenced 
by DNA structure. For example, in differential pulse polarography, the reduction peak of 
native dsDNA is almost two orders of magnitude smaller then the peak of denatured DNA 
[29] (Figure 2). 
 
 
Fig. 2 Redox signals with (a) dsDNA; and (b) ssDNA (single-strand DNA) at mercury 
electrode. 1- Differential pulse polarography; 2- Adsorptive stripping square wave 
voltammetry. Faradaic peaks: II – dsDNA, III – ssDNA. Non-Faradaic capacity 
peak I produced by both dsDNA and ssDNA [29]. 
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Also, the non-Faradaic capacity signals are highly sensitive to changes in DNA 
structure, and can provide information about the bases interactions with the electrode 
[29]. Since the electrochemical signals are strongly influenced by the DNA structure, 
mercury electrodes are more suitable for studies of DNA structural transitions and local 
conformational changes. Experiments with mercury electrodes have identified single-
strand (ss) interruptions in linear and circular DNA molecules, differences in the 
superhelix density of supercoiled DNAs, and superhelix density dependent structural 
transitions in DNA [30, 31]. According to all this, electrochemical analysis of DNA can, 
in principle, be performed without introducing any labels and additional reagents into 
DNA. Electrochemical reduction and oxidation of nucleobases are irreversible and do not 
allow reusability of these kind of biosensors. 
3.2.2. Non-covalently bound DNA redox indicators 
The use of DNA redox indicators is an alternative technique used to detect the 
presence of immobilized DNA as well as its interaction events such as hybridization, 
damage, and association with another substance. As already mentioned the reduction and 
oxidation of nucleic acids is chemically irreversible and occurs at highly negative or 
highly positive potentials. To increase the sensitivity of the measurements, non-covalently 
binding electroactive markers have been introduced into DNA. These markers undergo 
reversible electrode reaction at less extreme potentials. 
For this purpose soluble redox mediators such as Rh or Ru complexes are used to 
shuttle electrons from guanine residues in distant parts of DNA to the electrode [32]. The 
redox indicators usually show their electrochemical response at potentials different 
enough from the nucleobases, and it is often reversible. Some of the indicators interact with 
DNA through electrostatic forces [33], while others are present “free” in the solution phase. 
Cationic indicators like metal complex cations such as [Co(phen)3]
3+
 and [Co(bpy)3]
3+
 [34, 
35] can be attracted to DNA by negative charge of the backbone, while anionic indicators 
like [Fe(CN)6]
3-/4-
 can be repulsed. As a result of this, indicator voltammetric current 
response is lower and anodic to cathodic peak potential separation is higher than that 
observed at bare electrodes without DNA [33, 36]. The electrostatic indicators can also 
detect differences in negative charge density between ssDNA and dsDNA. 
Special kind of redox indicators are intercalators. Intercalators contain planar 
heterocyclic groups which stack between adjacent DNA base pairs, forming a complex 
which is stabilized by  stacking interactions between the intercalator and DNA. The 
most commonly used intercalators are drugs, especially anticancer agents. Intercalators 
can be mono- or bifunctional, depending on the number of aromatic moieties. There are 
simple mono-intercalators like acridine, and more complex like daunomycin and 
adriamycin, as well as bifunctional intercalators as echinomycin and triostin A (Table 1). 
Some DNA redox indicators intercalate into the dsDNA structure or bind to dsDNA 
grooves. The most famous minor groove binding drugs are netropsin, berenil, distamycin 
and mitramycin. They usually have crescent shape, which complements the shape of the 
groove [37, 38] and facilitates binding by promoting van der Waals interactions. 
Considerably small number of substances is reported to bind to major groove: the first reported 
agent was methyl green [39], and later on some antitumor [40], aminoglycoside antibiotics 
tobramycin, and other agents as pluramycins, aflatoxins, and azinomycins [41, 42]. 
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Table 1 Drugs interacting with DNA, non-covalently and covalently 
Intercalators 
Mono-intercalators Bifunctional intercalators 
 
Acridine 
 
 
 
 
 
R = H      Daunomycin 
R = OH   Adriamycin 
 
Drugs that covalently bind to DNA 
   
  
 
Cisplatin 
 
Mitomycin C 
 
Anthramycin 
Due to the accumulation within the immobilized dsDNA layer, the bound redox 
indicator exhibits a change in voltammetric response. As already mentioned, the most 
commonly used redox indicators are drugs, especially anticancer agents. For example, 
daunomycin can be oxidized at low potentials and high current density on a basal plane 
pyrolytic graphite electrode with an adsorbed DNA probe [43]. This kind of modified 
electrode detects electrochemical signal derived from an intercalator non-specifically 
bind to DNA. Voltammetric characteristics such as anodic and cathodic voltammetric 
peak potential and current obtained at modified graphite electrode are presented in 
Table 2 [43]. 
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Table 2 Anodic and cathodic voltammetric peak potential and current of some 
intercalators in phosphate buffer, pH 7.0. (Working electrode pyrolytic graphite, 
reference electrode Ag/AgCl, v = 25 mVs
-1
 [43].) 
Intercalator Epa (mV) ipa(A) Epc (mV) ipc(A) 
Anthracycline antibiotics 
Daunomycin 
Doxorubicin 
Pirarubicin 
Tetracycline antibiotics 
Tetracycline 
Doxycycline 
Minocycline 
Others 
7-Aminoactinomycin D 
Propidium iodide 
Quinacrine mustard 
Rifampicin 
 
446 
440 
446 
 
674 
663 
385 
 
651 
631 
688 
718 
 
2.06 
3.81 
1.47 
 
1.88 
2.79 
3.58 
 
1.34 
4.84 
2.54 
3.49 
 
394 
391 
389 
 
- 
- 
155 
 
376 
494 
-73 
44 
 
0.34 
0.41 
0.26 
 
- 
- 
0.42 
 
0.51 
1.03 
0.32 
0.57 
Glassy carbon electrode was used for electrochemical study of in situ anticancer drug 
adriamycin oxidative damage to DNA [44]. In the study of Tiware et al. [45], DNA modi-
fied glassy carbon fiber electrodes were used to study the interaction between the adri-
amycin and DNA. They reported a formation of an adriamycin radical which is able to 
oxidize the guanine in the dsDNA, thereby causing the decrease in the guanine oxidation 
peak. Voltammetric measurements on glassy carbon electrode showed that antileukemia 
drug glivec binds to dsDNA and leads to modifications in the dsDNA structure, recog-
nized through changes of the anodic oxidation peaks of guanine and adenine bases [46]. 
Using the same electrode, the decrease of the dsDNA oxidation peaks are detected upon 
the interaction of microcystin-LR and nodularin with DNA due to the aggregation of 
DNA strands which may cause the mutations in the dsDNA during the replication process 
[47]. Similar research involving another anticancer drugs, epirubicin [48] and mitoxan-
trone [49], reported a decrease in peak current obtained at modified carbon paste elec-
trode upon the interaction of these drugs with DNA. Recently, an anodically activated 
pencil graphite electrode (PGE) was employed for investigating the mechanism of the 
interaction between the anticancer drug leuprolide and fish sperm dsDNA, immobilized 
into the electrode surface [50].   
Mercury based electrodes are also used to investigate intercalation reactions mostly 
based on reduction processes. It is known that some intercalators could distinguish be-
tween dsDNA and ssDNA. Data obtained by voltammetric experiments using both the 
ssDNA and dsDNA modified electrode showed the type of binding of the intercalators. 
Bard and co-authors [34, 51, 52] reported that positive shifts of the peak potential were 
observed in the binding form via hydrophobic interactions (intercalation), while electro-
static interactions led to negative shift. Electrochemistry of anti tumor drugs echinomycin 
[53], and acridine [54], as well as nicotinic partial agonist varenicline [55], and their in-
teraction with DNA were studied on hanging mercury drop electrode. In all cases a for-
mation of drug-DNA complex was reported and the binding constant values determined. 
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Several other electrodes have been exploited in these studies. Among them modified gold 
surfaces are very often used. The self-assembled monolayers (SAMs) of an azidohexane thiol 
derivative were prepared on the Au electrode, and then used for the immobilization of dsDNA 
and investigation of interactions of taxol, a very important anticancer drug, and DNA [56]. This 
was done by monitoring the guanine oxidation peak current. Sun at al. [57] used daunomycin 
intercalated into a dsDNA as a biosensor to investigate the relation between peak current and 
the concentration of the DNA at modified gold electrode.  
Intercalators are also used as a part of DNA hybridization detectors. In an electro-
chemical DNA hybridization detector a short DNA probe is usually immobilized on elec-
trode to create a DNA recognition element. The probe-modified electrode is then im-
mersed into a solution of target DNA. When the target DNA contains a sequence that 
exactly matches that of the probe DNA, a hybrid duplex is formed at the electrode sur-
face. In the absence of complementarities between the probe and target, no duplex is 
formed. A DNA sensor recognizes the hybrids using an intercalator as an electrochemical 
probe. It is confirmed that intercalator is bound to hybrid more specifically than to DNA 
probe in order to detect a specific gene with high sensitivity [51]. 
Due to the recent progress in the analysis of nucleic acids, peptides and proteins, the 
electrochemical methods appear ready for application to sequence–specific and nonspe-
cific interactions of proteins with DNA. Peptides, polyaminoacids and proteins produce a 
structure–sensitive chronopotentiometric peak at mercury electrodes, which is due to the 
catalytic hydrogen evolution reaction. This characteristic reaction was used in the investi-
gation of basic protein like histones, binding to DNA [58], as well as in the research on 
the aggregation of α-synnuclein in Parkinson’s disease [59], and mutation of tumor sup-
pressor proteins p53 [60]. 
3.2.3. Covalently bound electrochemically active DNA labels 
Electrochemically active DNA labels (tracers) are compounds covalently bound to 
DNA, which are used for the DNA detection with improved analytical selectivity and 
specificity [22, 26, 61]. Most common used labels are modified ferrocene [62], nitro-
phenyl and aminophenyl groups, as well as osmium tetroxide complexes with nitrogen 
ligands [63-65]. Osmium tetroxide complexes were the first electroactive markers that 
were covalently bound to DNA. Some of these complexes bind preferentially to thymine 
residues in ssDNA, while others bind both to dsDNA and ssDNA. DNA adducts with 
these complexes produce reversible signals between -0.2V and -0.7V vs. Ag/AgCl/3M 
KCl at both carbon and mercury electrodes, and a high catalytic signal at -1.2V vs. 
Ag/AgCl/3M KCl at mercury electrodes. Using the catalytic signal, the sensitivity is two 
orders of magnitude higher than the signal of unmodified ssDNA (Figure 3), [29]. 
Some drugs interact covalently with DNA molecule [66]. Covalent binding in DNA is 
irreversible and undoubtedly leads to complete inhibition of DNA functions and subse-
quent cell death. The most famous covalent binder is Cisplatin (Table 1), which is used as 
an anticancer drug. When used for clinical practice, cisplatin is administered intrave-
nously. In the extracellular environment, where the chloride concentration is high, it does 
not undergo appreciable hydrolysis. 
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a)    b)  
Fig. 3  Differential pulse polarography of the complex obtained with OsO4 in the presence 
of 2,2'-bipy and thymine. Curve 1 – ssDNA modified with osmium complex; 
Curve 2 – unmodified ssDNA [29]. 
When cisplatin passes the cell membrane the reduced intracellular chloride concentra-
tion allows the chloro ligands to be replaced by water molecules to form cis-
[Pt(H2O)(NH3)2Cl]
+
 and cis-[Pt(H2O)2(NH3)2]
2+
. It is generally accepted that these two 
cations bind covalently to the electron-rich sites on DNA such as N-donor ligands [67]. 
The preferred target in DNA is guanine (G) since it has the highest electron density of all 
four nucleobases. It is believed that this reaction is responsible for the anticancer effect of 
cisplatin which is able to induce apoptosis/necrosis of the cancer cell [68]. 
The use of electrochemical techniques for studying platinum–DNA interactions were 
reported by Brabec [69] and by Erdem et al. [70], who studied the binding of cisplatin 
and a cisplatin-like chemotherapeutic agent to DNA which was coated on a wax- impreg-
nated graphite electrode and a pencil graphite electrode, respectively, by using  differen-
tial pulse voltammetry. Besides, Oliveira Brett et al. reported the electrochemical deter-
mination of carboplatin in serum using a DNA-modified glassy carbon electrode [71]. 
Mascini et al. have developed biosensors involving binding of cisplatin, carboplatin, 
platinum bipy and oxaliplatin [72-74] to double-stranded DNA immobilized on the sur-
face of screen-printed electrodes (SPEs). These biosensors use chronopotentiometry or 
square wave voltammetry (SWV), to rapidly and quantitatively measure the decrease of 
the oxidation peak of guanine. By calculating the ratio between the area (or height) of the 
guanine oxidation peak after interaction with the drug, and the area obtained by DNA 
alone, the percent of guanine sites in DNA that have not been modified by the interaction 
can be estimated. 
The attempt to use non-platinum metal complexes as anticancer agents was initiated with 
an idea to find less toxic and more specific drugs. Some ruthenium and titanium complexes 
showed promising pharmacological properties as antitumor and antimetastatic agents. The 
interaction of ruthenium(III) complex, NAMI-A, with dsDNA immobilized on screen-
printed electrodes was studied as a screening tool for in vitro DNA-drug interaction [75]. 
Titanium(IV) complex titanocene showed a lower degree of interaction with DNA than 
cisplatin since the ionic interaction between Ti cation and external phosphate backbone 
produces a minor effect on the oxidation of G with respect to the direct coordination [76]. 
This approach that has been successfully employed for the study of the interaction 
between a series of antitumor metallo-drugs and DNA offers information concerning the 
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reactivity of the metal complex, the effect of anions acting as leaving ligands, the affinity 
of the generated electrophilic agent to DNA, and the strength of perturbation caused in the 
DNA chain by these metallo-drugs. 
3.2.4. Nanostructured and magnetic materials 
In the last decade, the use of nanostructured materials is spreading in the field of na-
nosensors. This class of materials such as carbon nanotubes, magnetic nanoparticles or 
metal nanoparticles possesses very attractive features. Carbon nanotubes have recently 
attracted considerable attention due to their unique structural, electronic, mechanical and 
chemical properties [77]. The large specific surface and characteristic conducting proper-
ties allow them to achieve better response times, higher sensitivity and improved speci-
ficity [23]. Aligned carbon nanotubes were used to detect a DNA sequence characteristic 
for genetically modified organisms with sensitivity in the nanomolar range [24]. 
Magnetic separation represents an alternative method for DNA binding to solid sur-
face, which offers faster and less time consuming procedure. This method uses the mag-
netism for efficient separation of micrometer-sized paramagnetic or ferromagnetic parti-
cles from biological or chemical media. These particles, so called magnetic beads, be-
come magnetic under strong magnetic field, but retain no magnetism in the absence of 
magnetic field. Magnetic beads can be prepared in various ways. Usually particles sus-
ceptible to magnetism, such as iron oxide, are coated with biological or synthetic poly-
mers [78]. A combination of magnetic beads for immuno-magnetic separation and a later 
detection step using magnetic graphite-epoxy composite electrode has been recently em-
ployed for the detection of Salmonella in milk with the very low limit of detection [25]. 
Nanoparticles or nanocrystals of gold, silver, indium, zinc, cadmium or lead 
chalogenides have been used as well [79, 80]. 
A nanoparticle-based electrical detection of DNA hybridization, based on electrochemi-
cal stripping detection of the colloidal gold tag is reported by J. Wang et al. [81]. In this 
work the hybridization of a target oligonucleotide to magnetic bead-linked oligonucleotide 
probes is followed using an advanced magnetic processing technique to isolate the DNA 
duplex and to provide low-volume mixing. Another electrochemical DNA detection method 
has been developed for the sensitive quantification of an amplified human cytomegalovirus 
DNA sequence (HCMV DNA). The assay relies on the hybridization of the single-stranded 
target HCMV DNA with an oligonucleotide-modified Au nanoparticle probe, followed by 
the release of the gold metal atoms, anchored on the hybrids by oxidative metal dissolution, 
and the indirect determination of the solubilized Au(III) ions by anodic stripping voltamme-
try at a sandwich-type screen-printed microband electrode (SPMBE) [82]. 
An electrochemical DNA hybridization detection assay, using silver nanoparticles as 
the oligonucleotide labeling tag, is reported [83]. The assay relies on the hybridization of 
the target DNA with the silver nanoparticle–oligonucleotide DNA probe, followed by the 
release of the silver metal atoms, its oxidative dissolution and indirect determination of 
the solubilized Ag(I) ions by anodic stripping voltammetry (ASV) at a carbon fiber ultra-
microelectrode. Finally, Wang and coauthors proposed silver-enhanced colloidal gold 
stripping detection strategy for the detection of DNA hybridization which represents an 
alternative to indirect optical affinity assays of nucleic acids and other biomolecules [84]. 
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4. CONCLUSIONS 
Having in mind that DNA is one of the most important biomacromolecules, the possi-
bility of construction of DNA-based sensor deserves great attention. Such biosensor is 
simple, fast, cheap, miniaturized and easy-controlled analytical device for investigation 
DNA chemical and physical interactions with other small molecules in vitro. According to 
all these properties, it is understandable that DNA biosensors are finding their application 
as drug investigation devices, in chemical toxicity tests, and in food and water analysis. 
Besides, these biosensors are used for fundamental evaluation of effects of antioxidants, 
and investigation of interactions of nucleic acids with other biomacromolecules such as 
proteins, that contributes to development of molecular diagnostics. 
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PRIMENA ELEKTROHEMIJSKIH BIOSENZORA ZA 
ISPITIVANJE STRUKTURE, OŠTEĆENJA I INTERAKCIJA DNK 
SA DRUGIM MOLEKULIMA 
Poslednjih godina je postignut veliki napredak u razvoju elektrohemijskih biosenzora za ispitivanja 
sekvenci, hibridizacije i oštećenja na molekulu DNK. Primenom elektrohemijskih metoda se u današnje 
vreme mogu detektovati i određivati nanomolarne koncentracije DNK. Pored toga, ove metode su 
pogodne za ispitivanje kako kovalentnih, tako i nekovalentnih interakcija između DNK i različitih malih 
molekula, kakvi su lekovi i drugi potencijalno mutageni agensi. Ovo sugeriše da bi elektrohemijski 
biosenzori mogli biti od značaja i u oblast medicinskih istraživanja. Cilj ovoga preglednog rada je da 
skrene pažnju na primenljivost različitih elektrohemijskih metoda za proučavanje interakcija između DNK 
i drugih molekula, kao i u izradu novih osetljivih i selektivnih biosenzora. 
Ključne reči: elektrohemijski biosenzor, DNK, interakcije, oštećenja 
